Epidermodysplasia verruciformis associated with plasmablastic lymphoma and hepatitis B virus infection. 2012

Nasrin Shayanfar, and Pegah Babaheidarian, and Hoda Rahmani, and Keyhan Azadmanesh, and Amir Sohrabi, and Masoud Mohammadpour, and Ali Zare Mirzaie, and Nima Parvaneh
Department of Pathology, Hazrat-e-Rasoul Hospital, Teheran University of Medical Sciences, Iran. nasrin.shayanfar@gmail.com

Epidermodysplasia verruciformis is a rare genodermatosis characterized by inherited susceptibility to infection with certain papillomaviruses, which leads to the development of disseminated plane wart-like lesions. In some patients, lesions resembling pityriasis versicolor appear. Epidermodysplasia verruciformis has also been reported in immunosuppressed patients, most notably those with HIV infection. The affected patients are predisposed to development of skin and mucosal malignancies. We describe the rare occurrence of plasmablastic lymphoma in a patient with long lasting epidermodysplasia verruciformis and hepatitis B virus infection.

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004819 Epidermodysplasia Verruciformis An autosomal recessive trait with impaired cell-mediated immunity. About 15 human papillomaviruses are implicated in associated infection, four of which lead to skin neoplasms. The disease begins in childhood with red papules and later spreads over the body as gray or yellow scales. Lewandowsky-Lutz Disease,Lutz-Lewandowsky Disease,Disease, Lewandowsky-Lutz,Disease, Lutz-Lewandowsky,Lewandowsky Lutz Disease,Lutz Lewandowsky Disease
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

Nasrin Shayanfar, and Pegah Babaheidarian, and Hoda Rahmani, and Keyhan Azadmanesh, and Amir Sohrabi, and Masoud Mohammadpour, and Ali Zare Mirzaie, and Nima Parvaneh
March 1979, The Journal of investigative dermatology,
Nasrin Shayanfar, and Pegah Babaheidarian, and Hoda Rahmani, and Keyhan Azadmanesh, and Amir Sohrabi, and Masoud Mohammadpour, and Ali Zare Mirzaie, and Nima Parvaneh
January 1991, The British journal of dermatology,
Nasrin Shayanfar, and Pegah Babaheidarian, and Hoda Rahmani, and Keyhan Azadmanesh, and Amir Sohrabi, and Masoud Mohammadpour, and Ali Zare Mirzaie, and Nima Parvaneh
February 2010, The Journal of pediatrics,
Nasrin Shayanfar, and Pegah Babaheidarian, and Hoda Rahmani, and Keyhan Azadmanesh, and Amir Sohrabi, and Masoud Mohammadpour, and Ali Zare Mirzaie, and Nima Parvaneh
May 2004, Clinical and experimental dermatology,
Nasrin Shayanfar, and Pegah Babaheidarian, and Hoda Rahmani, and Keyhan Azadmanesh, and Amir Sohrabi, and Masoud Mohammadpour, and Ali Zare Mirzaie, and Nima Parvaneh
December 2011, Journal of Crohn's & colitis,
Nasrin Shayanfar, and Pegah Babaheidarian, and Hoda Rahmani, and Keyhan Azadmanesh, and Amir Sohrabi, and Masoud Mohammadpour, and Ali Zare Mirzaie, and Nima Parvaneh
April 1986, Journal of the American Podiatric Medical Association,
Nasrin Shayanfar, and Pegah Babaheidarian, and Hoda Rahmani, and Keyhan Azadmanesh, and Amir Sohrabi, and Masoud Mohammadpour, and Ali Zare Mirzaie, and Nima Parvaneh
September 1992, Journal of the American Academy of Dermatology,
Nasrin Shayanfar, and Pegah Babaheidarian, and Hoda Rahmani, and Keyhan Azadmanesh, and Amir Sohrabi, and Masoud Mohammadpour, and Ali Zare Mirzaie, and Nima Parvaneh
January 2007, Pediatric dermatology,
Nasrin Shayanfar, and Pegah Babaheidarian, and Hoda Rahmani, and Keyhan Azadmanesh, and Amir Sohrabi, and Masoud Mohammadpour, and Ali Zare Mirzaie, and Nima Parvaneh
April 2013, Dermatology online journal,
Nasrin Shayanfar, and Pegah Babaheidarian, and Hoda Rahmani, and Keyhan Azadmanesh, and Amir Sohrabi, and Masoud Mohammadpour, and Ali Zare Mirzaie, and Nima Parvaneh
March 1984, Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
Copied contents to your clipboard!